ORGANOGENESIS HOLDINGS INC. Accounts Receivable, Allowance for Credit Loss, Recovery
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. accounts receivable, allowance for credit loss, recovery for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. accounts receivable, allowance for credit loss, recovery for the quarter ending 2025-09-30 was $1.00K.
- ORGANOGENESIS HOLDINGS INC. accounts receivable, allowance for credit loss, recovery for the quarter ending 2025-06-30 was $1.00K.
- ORGANOGENESIS HOLDINGS INC. accounts receivable, allowance for credit loss, recovery for the quarter ending 2025-03-31 was $2.00K, a 33.33% decline year-over-year.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 3 month | Accounts Receivable, Allowance for Credit Loss, Recovery 6 month | Accounts Receivable, Allowance for Credit Loss, Recovery 9 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $1.00K 10-Q · filed 2025-11-06 | $2.00K derived: sum of 2 quarters · filed 2026-08-06 | $4.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.00K 10-Q · filed 2026-08-06 | $3.00K 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $2.00K 10-Q · filed 2025-05-08 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $3.00K 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $3.00K 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |